Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.26B P/E - EPS this Y 417.90% Ern Qtrly Grth -
Income 57.16M Forward P/E -58.19 EPS next Y 130.70% 50D Avg Chg 3.00%
Sales 95.95M PEG - EPS past 5Y - 200D Avg Chg 40.00%
Dividend N/A Price/Book 6.65 EPS next 5Y - 52W High Chg -4.00%
Recommedations 1.50 Quick Ratio 12.29 Shares Outstanding 28.56M 52W Low Chg 107.00%
Insider Own 12.76% ROA -4.97% Shares Float 20.74M Beta 0.86
Inst Own 91.45% ROE 8.87% Shares Shorted/Prior 2.45M/2.24M Price 126.28
Gross Margin 94.25% Profit Margin 59.57% Avg. Volume 308,996 Target Price 189.00
Oper. Margin 12.85% Earnings Date Aug 5 Volume 163,537 Change -3.03%
About Krystal Biotech, Inc.

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). The company also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Krystal Biotech, Inc. News
06:00 AM Krystal Biotech to Present at BofA Securities 2024 Health Care Conference
05/07/24 Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript
05/07/24 Krystal Biotech Inc (KRYS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...
05/06/24 Q1 2024 Krystal Biotech Inc Earnings Call
05/06/24 Krystal Biotech Inc (KRYS) Surpasses Revenue Estimates in Q1 2024
05/06/24 Krystal Biotech, Inc. (KRYS) Q1 Earnings and Revenues Miss Estimates
05/06/24 Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates
05/03/24 Why Krystal Biotech (KRYS) Might Surprise This Earnings Season
05/02/24 Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
04/26/24 Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
04/23/24 Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a Turnaround
04/22/24 Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
04/17/24 Krystal Biotech (KRYS) is on the Move, Here's Why the Trend Could be Sustainable
04/15/24 Recent 3.8% pullback isn't enough to hurt long-term Krystal Biotech (NASDAQ:KRYS) shareholders, they're still up 437% over 5 years
04/04/24 Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting
04/01/24 Recent Price Trend in Krystal Biotech (KRYS) is Your Friend, Here's Why
03/27/24 3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List
03/14/24 Krystal Biotech, Inc. (KRYS) Is a Great Choice for 'Trend' Investors, Here's Why
12:20 PM Can Krystal Biotech, Inc. (KRYS) Run Higher on Rising Earnings Estimates?
12:00 PM What Makes Krystal Biotech, Inc. (KRYS) a New Buy Stock
KRYS Chatroom

User Image FlynancialAnalyst Posted - 3 hours ago

$TSLA wkly gap fill into 10 wk SMA and VWAP ? ✅ Now let's $SPOT the 🧠📈 send an $MSOS to the mkt thru EoW to make it $KRYS tal clear $COCO

User Image FlynancialAnalyst Posted - 22 hours ago

$XBI otech $KRYS tal ball sending hints into the close 🔮

User Image xbibackto70s Posted - 1 day ago

Yesterday was $krys

User Image Quantumup Posted - 1 day ago

BofA trims PT $KRYS $195 was $200/Buy~to reflect lower cash position📝there are 400 free vials from J-code switch which=approx $9M in missed revenue and if included it would have been a beat; miss should not warrant any concern on longer-term launch and they expects Vyjuvek sales to rebound: ⬆️EPS Est:

User Image erevnon Posted - 1 day ago

HC Wainwright & Co. reiterates Krystal Biotech $KRYS at Buy and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

User Image FlynancialAnalyst Posted - 2 days ago

100 $PRCT $CENT chance $KRYS is a $MNDY shake into the 20 wk SMA?

User Image cubie Posted - 2 days ago

@kindness123 @simon58 @jenbunn @jargv @randydeansr @ribbey @SamwiseTheBrave @TraderRapp @tonyctl @tigerknee cubie thought about 150 puts on $krys (wen was 156s) but no fill and canceled🙄😑😅. And np tiger, $tsn u didn't play either. so only cubie😬🤨. guys there were couple stocks earnings (other than 3 bios). either $tsn or $frpt. so not rocket science what cubie watching if opportunity arose.🤔😑 Cubie teaches play the big movers! 😬

User Image cubie Posted - 2 days ago

@simon58 @Ykante1997 @jenbunn @jargv @randydeansr @ribbey @kindness123 @SamwiseTheBrave @TraderRapp @tonyctl $krys bios are cray cray movers😆

User Image cubie Posted - 2 days ago

@kenny91655 @kindness123 congrats $krys

User Image cubie Posted - 2 days ago

@simon58 @Ykante1997 @jenbunn @jargv @randydeansr @ribbey @kindness123 @SamwiseTheBrave @TraderRapp @Eagles78 OK $krys calls tripled from 1.50

User Image cubie Posted - 2 days ago

$KRYS u had ur chance, @kindness123 saw $130s too, now it's $20+$25 higher😬😅

User Image cubie Posted - 2 days ago

$Krys congrats early birds who got the worm🤑😅

User Image cubie Posted - 2 days ago

@kindness123 @simon58 @jargv @jenbunn @ribbey @SamwiseTheBrave @TraderRapp @tonyctl @Eagles78 @lukenight $prft buyout, nothing burger now😅 $Krys there goes cubie grand 😅 but it tanked twice as much earlier and bounced back, guess what...half that drop, can't make this sht up.

User Image GetVector Posted - 2 days ago

Vector Intelligence (VI) is an algorithm designed to predict potential outsized intraday moves. VI will select up to 4 stocks per day. Today's VI stocks: $EYPT, $FRPT, $KRYS.

User Image OpenOutcrier Posted - 2 days ago

$KRYS (-15.0% pre) Krystal Biotech misses top-line and bottom-line estimates; reaffirms FY24 outlook - SA https://ooc.bz/l/32338

User Image kindness123 Posted - 2 days ago

$KRYS oops 😬😅

User Image kindness123 Posted - 2 days ago

@tonyctl @lukenight @cubie @ribbey @TraderRapp @SamwiseTheBrave @jenbunn @Eagles78 @jargv @simon58 $KRYS no buenos this earning like last 😅

User Image Zeldarules Posted - 2 days ago

$KRYS obliterated

User Image kenny91655 Posted - 2 days ago

$KRYS Good day to get in under 140

User Image xbibackto70s Posted - 2 days ago

$KRYS not good earnings

User Image Stock_Titan Posted - 2 days ago

$KRYS Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates https://www.stocktitan.net/news/KRYS/krystal-biotech-announces-first-quarter-2024-financial-results-and-zahdzm16j101.html

User Image cubie Posted - 4 days ago

@kindness123 @simon58 @jargv @jenbunn @randydeansr @ribbey @TraderRapp @SamwiseTheBrave @tigerknee @lukenight 1 itm $16 con on $krys for fun for $11😅

User Image cubie Posted - 4 days ago

$KRYS looks bullish @Eagles78 ,😅, last time Krystal ripped from $110 to $160 on earnings

User Image eWhispers Posted - 5 days ago

#earnings before the open on Monday, May 6, 2024 https://www.earningswhispers.com/calendar #SAVE $KRYS $BNTX $AXSM $BRK.B (really Saturday)

User Image Stock_Titan Posted - 6 days ago

$KRYS Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting https://www.stocktitan.net/news/KRYS/krystal-biotech-to-present-at-the-association-for-research-in-vision-nhrevbnu23oy.html

User Image Stock_Titan Posted - 04/26/24

$KRYS Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024 https://www.stocktitan.net/news/KRYS/krystal-biotech-to-report-first-quarter-2024-financial-results-on-15ie3pmgzqiz.html

User Image Ldx Posted - 04/23/24

$KRYS Owned this long ago and gave up and sold. Surprised to see where it is today. Awesome for those who held on!

User Image kenny91655 Posted - 04/22/24

$KRYS CRL for Abeona. CMC data to be given to FDA in third quarter.

User Image Stock_Titan Posted - 04/22/24

$KRYS Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung https://www.stocktitan.net/news/KRYS/krystal-biotech-announces-first-patient-dosed-in-phase-1-clinical-eubwo6fzr2bp.html

User Image kenny91655 Posted - 04/19/24

$KRYS Started repurchasing again. The next report will include 12.5 million payment to lawsuit victors. 100 million, 200 and 300 million, each 12.5 million.

Analyst Ratings
HC Wainwright & Co. Buy May 6, 24
HC Wainwright & Co. Buy Apr 22, 24
Stifel Buy Apr 16, 24
Citigroup Buy Feb 27, 24
Guggenheim Buy Feb 27, 24
Cantor Fitzgerald Overweight Dec 13, 23
Goldman Sachs Buy Nov 20, 23
Cantor Fitzgerald Overweight Nov 7, 23
Cantor Fitzgerald Overweight Oct 24, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Romano Kathryn Chief Accounting Off.. Chief Accounting Officer Jan 22 Sell 130 2,500 325,000 12,556 01/24/24
Romano Kathryn Chief Accounting Off.. Chief Accounting Officer Jan 22 Option 52.26 2,500 130,650 15,056 01/24/24
Krishnan Suma President, R&D President, R&D Dec 11 Sell 105.84 50,000 5,292,000 1,634,338 12/12/23
Krishnan Krish S President and CEO President and CEO Dec 11 Sell 105.84 50,000 5,292,000 1,574,206 12/12/23
Krishnan Suma President, R&D President, R&D Sep 11 Sell 127.21 50,000 6,360,500 1,659,338 09/12/23
Krishnan Krish S President and CEO President and CEO Sep 11 Sell 127.21 50,000 6,360,500 1,599,206 09/12/23
JANNEY DANIEL Director Director Jun 08 Sell 128.46 50,000 6,423,000 107,362 06/09/23
ORTH ANDREW C. Chief Commercial Off.. Chief Commercial Officer Jun 09 Sell 128.92 12,500 1,611,500 100 06/09/23
ORTH ANDREW C. Chief Commercial Off.. Chief Commercial Officer Jun 09 Option 63.55 12,500 794,375 12,600 06/09/23
Krishnan Suma President, R&D President, R&D May 31 Sell 116.83 50,000 5,841,500 1,684,338 06/02/23
Krishnan Krish S President and CEO President and CEO May 31 Sell 116.83 50,000 5,841,500 1,624,206 06/02/23
JANNEY DANIEL Director Director Apr 19 Sell 90.3156 7,900 713,493 224,462 04/21/23
ROSSI DINO A Director Director Mar 01 Sell 83.2493 40,000 3,329,972 83,691 03/02/23
Krishnan Suma President, R&D President, R&D Jan 17 Sell 81.43 50,000 4,071,500 1,738,688 01/19/23
Krishnan Krish S President and CEO President and CEO Jan 17 Sell 81.43 50,000 4,071,500 1,677,263 01/19/23
Krishnan Suma President, R&D President, R&D Jan 04 Sell 80.08 7,686 615,495 1,763,688 01/05/23
Krishnan Krish S President and CEO President and CEO Jan 04 Sell 80.08 7,686 615,495 1,702,263 01/05/23
Krishnan Suma President, R&D President, R&D Dec 29 Sell 80.57 19,422 1,564,831 1,767,436 01/03/23
Krishnan Krish S President and CEO President and CEO Dec 29 Sell 80.57 19,422 1,564,831 1,706,201 01/03/23
Krishnan Suma President, R&D President, R&D Dec 16 Sell 80.1 21,099 1,690,030 1,777,146 12/20/22
Krishnan Krish S President and CEO President and CEO Dec 16 Sell 80.1 21,099 1,690,030 1,715,913 12/20/22
Krishnan Suma President, R&D President, R&D Nov 23 Sell 80.01 4 320 1,787,718 11/28/22
Krishnan Krish S President and CEO President and CEO Nov 23 Sell 80.01 4 320 1,787,718 11/28/22
Krishnan Suma President, R&D President, R&D Aug 05 Sell 81.35 50,000 4,067,500 1,788,688 08/09/22
Krishnan Krish S President and CEO President and CEO Aug 05 Sell 81.35 50,000 4,067,500 1,727,263 08/09/22